BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 3948063)

  • 1. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of refractory cardiac arrhythmias with amiodarone.
    Leak D; Eydt JN
    Arch Intern Med; 1979 Apr; 139(4):425-8. PubMed ID: 434996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amiodarone therapy in childhood: efficacy and side effects].
    Vignati G; Danzi GB; Austoni P; Fancini P; Mascarello M; Figini A
    G Ital Cardiol; 1985 Aug; 15(8):786-94. PubMed ID: 2935440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia.
    Celiker A; Koçak G; Lenk MK; Alehan D; Ozme S
    Turk J Pediatr; 1997; 39(2):219-25. PubMed ID: 9223920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent].
    Malpartida F; Triola M; Huguet R; Sala J; Noguera J; Cordeiro B
    Rev Med Univ Navarra; 1975; 19(1):143-9. PubMed ID: 1234780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations.
    Installe E; Schoevaerdts JC; Gadisseux P; Charles S; Tremouroux J
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):302-8. PubMed ID: 7453241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome.
    Shahar E; Barzilay Z; Frand M; Feigl A
    Pediatrics; 1983 Dec; 72(6):813-6. PubMed ID: 6646922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
    Lloyd EA; Mabin TA
    S Afr Med J; 1983 May; 63(20):759-63. PubMed ID: 6342169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrocardiographic effects and antiarrhythmic action of 1200 mg of oral amiodarone per day].
    Tonet JL; Lechat P; Frank R; Lascault G; Fontaine G; Facquet J; Cohen A; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1984; 33(5):309-15. PubMed ID: 6476769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
    Manning AS; Bruyninckx C; Ramboux J; Chatelain P
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):453-61. PubMed ID: 8583788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.